拉脱维亚2017至2019年甲型肝炎暴发与散发病例的分子流行病学
拉脱维亚在2017至2019年报告了179例实验室确诊甲型肝炎病例,研究对125份血清样本进行HAV VP1/P2A基因组区扩增测序,发现多数为IA亚型(n=77),其中41株与欧洲男男性行为者(MSM)人群流行株相关,另有44例IB亚型和4例IIIA亚型。分子分型方法有助于识别公共卫生所需的聚集簇并建立与其他暴发的关联。
要点
- 2017至2019年拉脱维亚报告179例甲型肝炎确诊病例,其中69.8%的样本进行了分型。
- 125份血清样本测序显示,IA亚型77株,其中41株为欧洲MSM人群流行株。
- 分子分型可识别聚集簇、建立与其他暴发的关联并比较跨国毒株。
核心结论
- 拉脱维亚2017至2019年甲型肝炎病例增加,分子分型显示多数为IA亚型,部分与欧洲MSM人群流行株相关,同时存在其他聚集簇和散发病例。
研究设计与样本
- 对2017至2019年拉脱维亚报告的179例实验室确诊甲型肝炎病例中的125份血清样本进行HAV VP1/P2A基因组区扩增和测序,并分析测序病例的肝炎相关症状、住院、疫苗接种、可能感染来源和可疑病毒来源国信息。
主要发现
- 179例实验室确诊病例中,69.8%的HAV样本进行了分型。
- 125份测序样本中,IA亚型77株,其中41株为欧洲MSM人群流行株:VRD_521_2016(n=32)、RIVM-HAV16-090(n=7)或V16-25801(n=2)。
- 44例为IB亚型,4例为IIIA亚型。
- 检测到其他聚集簇和散发病例,部分有或没有识别出流行病学关联。
临床怎么用
- 分子分型方法可用于公共卫生需求中的聚集簇识别、与其他暴发的关联建立以及拉脱维亚毒株与国外报告毒株的比较。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundHepatitis A is an acute infection of the liver caused by hepatitis A virus (HAV). Molecular detection and typing of the HAV VP1/P2A genomic region is used for genotyping and outbreak investigations. After a large hepatitis A outbreak in Latvia in 2007-08, only sporadic cases were registered until 2017 when a rise in cases occurred. During 2017-19, 179 laboratory-confirmed hepatitis A cases were notified in Latvia.AimTo investigate the observed increase in hepatitis A cases during 2017 and to determine whether these cases were linked to one another, to risk groups, or to other outbreaks. The majority of HAV samples (69.8%) were typed.MethodsThe VP1/P2A genomic region of HAV was amplified and sequenced for 125 case serum samples. Information about hepatitis-related symptoms, hospitalisation, vaccination, a possible source of infection and suspected countries of origin of the virus were analysed for sequenced cases.ResultsMost HAV strains were subgenotype IA (n = 77), of which 41 were strains circulating among men who have sex with men (MSM) populations in Europe (VRD_521_2016 (n = 32), RIVM-HAV16-090 (n = 7) or V16-25801 (n = 2)). Forty-four cases were subgenotype IB and four cases subgenotype IIIA. However, other clusters and sporadic cases were detected with or without identifying the epidemiological link.ConclusionThis work represents molecular epidemiological data of hepatitis A cases in Latvia from 2017 to 2019. Molecular typing methods allow identification of clusters for public health needs and establishing links with other outbreaks, and to compare Latvian strains with reported strains from other countries.
引用
- Savicka O, Zeltmatis R, Storozenko J, et al. Molecular epidemiology of hepatitis A outbreaks and sporadic cases, Latvia, 2017 to 2019. Euro Surveill. 2022. PMID: 35301978. doi:10.2807/1560-7917.ES.2022.27.11.2100415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。